Aspire Private Capital, LLC Biond Vax Pharmaceuticals Ltd. Transaction History

Aspire Private Capital, LLC

  • $416 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
BUY
$1.16 - $1.88 $927 - $1,504
800 Added 100.0%
1,600 $2,000
Q1 2022

May 10, 2022
BUY
$1.15 - $2.34 $919 - $1,872
800 New
800 $1,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email